May 28, 2021
Seven RGW physicians were included among the Maryland-Virginia-D.C. area’s best ophthalmologists in the Washingtonian Magazine’s “Top Doctors” listing as chosen by their peers in the field. Dr. Mohammed K. Barazi, T. Mark Johnson, Reshma C. Katira, Aziz A. Khanifar, Eric S. Lee, Alex Melamud and Frank A. Spellman were the doctors named in the annual rankings.
Read More
May 28, 2021
Drs. Eric D. Weichel & Marcus H. Colyer co-authored an article in a recent issue of Ophthalmology Journal on Military Combat-Related Intraocular Foreign Body Injuries. The findings—first presented at the American Academy of Ophthalmology’s Annual Meeting—documented trauma in both Operation Iraqi Freedom and Operation Enduring Freedom.
Read More
May 28, 2021
The Retina Group of Washington (RGW), the leading provider of retinal and macular care in the Washington, D.C. metropolitan area, has announced it is merging with Retina Associates (RA) effective January 1, 2019. RGW currently has 14 offices in Maryland, Virginia and the District and totals 26 full-time physicians who provide expertise in a variety […]
Read More
May 28, 2021
Dr. John R. Minarcik, who also sees patients in the Ophthalmology Clinic at Fort Belvoir Community Hospital, was rated the top Specialty Care Provider in the entire U.S. Military Health System. According to the 2017 JOES (Joint Outpatient Experience Survey) “Best of the Best” Annual Survey, he received hundreds of positive comments and received a […]
Read More
May 28, 2021
Dr. Reginald J. Sanders served as a guest panelist at the recent Vit-Buckle Society 6th Annual Meeting, participating in a discussion entitled “Real World Retina.” The society provides an open forum that mentors developing vitreoretinal surgeons, nurtures innovative surgical techniques and therapeutic approaches for retinal diseases, and fosters best practices.
Read More
May 28, 2021
Dr. Daniel M. Berinstein co-authored a SCORE2 trial paper—published in a recent issue of JAMA Ophthalmology—that looked at patients receiving monthly injections vs. treat-and-extend regimens in a study of comparative treatments for Retinal Vein Occlusion. The multi-center, prospective, randomized trial, sponsored by the National Eye Institute (NEI), compared intravitreal bevacizumab (Avastin) to aflibercept (Eylea) for the […]
Read More
May 28, 2021
Uveitis is often defined as a group of inflammatory diseases that produces interocular inflammation and destroys eye tissues. Often misdiagnosed and mistreated, it frequently affects the part of the eye called the uvea–the “middle” layer that contains much of its blood vessels–but also can affect the lens, retina, optic nerve and vitreous. And until recently, […]
Read More
May 28, 2021
Since joining The Retina Group of Washington as a Fellow just a few short years ago, Dr. Joshua D. Levinson has fashioned a formidable record of published research remarkable for a younger doctor. It is his most recent work on improving the safety of intravitreal injections that is perhaps the most meaningful to date; his […]
Read More